...selectively enhancing Treg activity in autoimmune diseases include Delinia Inc. , Caladrius Biosciences Inc. (NASDAQ:CLBS), Iltoo Pharma...
...Institute , Seattle, Wash. Business: Gene/Cell therapy, Autoimmune Mary Romeo Bayer AG Caladrius Biosciences Inc. Celgene Corp. CRISPR Therapeutics AG Delinia Inc. Iltoo Pharma Seattle...

...of selectively enhancing Treg activity in autoimmune diseases include Delinia Inc., Caladrius Biosciences Inc. (NASDAQ:CLBS), Iltoo Pharma...
...this year (see BioCentury Innovations, Oct. 13, 2016) . Mary Romeo Bayer AG Caladrius Biosciences Inc. Celgene Corp. CRISPR Therapeutics AG Iltoo Pharma Seattle...

...is just high enough to activate the high-affinity Treg receptor without activating the low-affinity counterpart. Iltoo Pharma...
...Companies and Institutions Mentioned Caladrius Biosciences Inc. (NASDAQ:CLBS), New York, N.Y. Delinia Inc., Cambridge, Mass. Iltoo Pharma...